Olivier Dormond
Lausanne, VD 1011, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.
Journal: Life (Basel, Switzerland)
Published: March 28, 2023
Carcinogenic effect of arsenic in digestive cancers: a systematic review.
Journal: Environmental health : a global access science source
Published: December 14, 2022
Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 28, 2022
Mechanosensitive mTORC1 signaling maintains lymphatic valves.
Journal: The Journal of cell biology
Published: July 13, 2022
Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.
Journal: Molecular genetics and metabolism
Published: May 31, 2022
Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
Journal: International journal of molecular sciences
Published: March 31, 2022
Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells.
Journal: International journal of molecular sciences
Published: May 02, 2021
Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets.
Journal: Cancers
Published: April 15, 2021
Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study.
Journal: World journal of surgery
Published: March 26, 2021
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment.
Journal: Cancers
Published: January 29, 2021
Last Updated: 09/26/2026